320 results
Posted on 02.02.2021
Biobanks and medtech: an underdeveloped partnership
Unlocking academia-industry collaboration on sample collection, storage and sharing COVID-19 has demonstrated that access to quality samples and clinical data is key to facing any healthcare challenge. Millions of people have been tested around the world, generating an enormous number of samples and patients’ data. Of course, swabs can have a life after the results […]
Posted on 10.12.2020
Accelerating medtech innovation in paediatrics
For start-ups working in paediatrics, competitions can offer funding, exposure and invaluable access to mentorship. Despite advances in medical technology, the fruits of progress are not shared equally across age groups. One of the biggest challenges we see in the paediatric domain, and especially among those younger in the age spectrum, is the lack […]
Posted on 26.11.2020
In vitro diagnostics at risk: Covid-19 delays progresses towards the new European regulations
In order to keep them available to the health care system and to patients, more than 85% of IVDs will need to be updated in view of the new in vitro Diagnostic Regulation (IVDR) which is at risk due to the ongoing COVID-19 pandemic. The remaining IVDR transition time is not sustainable and requires attention […]
Posted on 03.11.2020
Current trends in tendering innovation at risk
Medical technology procurement must focus on quality if it is to deliver value Tenders for medical devices across Europe are increasingly focused on price only. This is one of the key findings of a recent analysis “Tendering Medical Devices in Europe – Strategy & Implications for Pricing” that we conducted on tenders from 2016 to […]
Posted on 26.10.2020
COPD & COVID-19: Pandemic must prompt shift to connected care
For people living with chronic obstructive pulmonary disease (COPD), a long-term lung illness, COVID-19 is having a major impact. The pandemic has disrupted traditional models of care and put vulnerable patients at risk. Keeping patients out of hospital – by reducing scheduled visits and avoiding emergency admissions – has become the top priority. A silver […]
Posted on 20.10.2020
In crisis, medtech found the path to realise its full potential
I have been truly humbled by the collective response of the medical technology industry through this pandemic. As we approach MedTech Week 2020, our industry can be proud of the contribution we have made. But as we reflect on the impact of this unprecedented year, perhaps the true legacy has yet to reveal itself: how […]
Posted on 21.09.2020
EU Health PPP: a new era for medtech companies
For decades, companies in the medtech and pharma sectors have delivered healthcare innovations separately – collaboration has been limited. However, we know that this is not how patients experience healthcare. In the real world, diagnostics, devices, medicines, vaccines and digital tools combine to keep people healthy and to treat those who are unwell. This reality […]
Posted on 22.07.2020
MedTech Facts (and Figures) everyone should know
‘Data-driven decision making’ has become a buzzword in policy discussions throughout the past years. On one hand, from a supply point of view, with the digital revolution we generate and have access to an ever-growing pool of data. We continuously collect and analyse information about every aspect of our life, whether personal or professional. On […]
Posted on 17.07.2020
The rise of the humble medical mask
This blog is part of a blog series that showcases the medtech role in the different phases of the COVID-19 pandemic. Read here more COVID-19 related blogs. More info on MedTech Europe’s info hub. The medical mask was a product once taken for granted, but now is being recognised as a vital tool for public health. […]